TYMS and rectal cancer: A previous study revealed that TS mRNA expression in rectal cancer patients with the TS-3′-UTR −6/−6 and −6/+6 genotypes was significantly lower compared with patients with the TS-3′-UTR +6/+6 genotype, resulting in a favorable outcome following neoadjuvant 5-FU-based chemoradiation (29).